🚀 VC round data is live in beta, check it out!
Double Bond Valuation Multiples
Discover revenue and EBITDA valuation multiples for Double Bond and similar public comparables like Cannabis Poland, HCW Biologics, JFL Life Sciences, Geovax Labs and more.
Double Bond Overview
About Double Bond
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
Founded
1919
HQ
Employees
9
Website
Sectors
Financials (FY)
EV
$3M
Double Bond Financials
Double Bond reported last fiscal year revenue of $9K and negative EBITDA of ($2K).
In the same fiscal year, Double Bond generated $623K in gross profit, ($2K) in EBITDA losses, and had net loss of ($36K).
Double Bond P&L
In the most recent fiscal year, Double Bond reported revenue of $9K and EBITDA of ($2K).
Double Bond expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $9K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $623K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 6775% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (22%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (2006%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($36K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (395%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Double Bond Stock Performance
Double Bond has current market cap of $3M, and enterprise value of $3M.
Market Cap Evolution
Double Bond's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $3M | 0.3% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDouble Bond Valuation Multiples
Double Bond trades at 337.8x EV/Revenue multiple, and (1548.2x) EV/EBITDA.
Double Bond Financial Valuation Multiples
As of April 19, 2026, Double Bond has market cap of $3M and EV of $3M.
Equity research analysts estimate Double Bond's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Double Bond has a P/E ratio of (89.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 337.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1548.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (16.8x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.0x | XXX | XXX | XXX |
| P/E | — | XXX | (89.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (6.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Double Bond Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Double Bond Margins & Growth Rates
Double Bond's revenue in the last fiscal year declined by (92%).
Double Bond's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Double Bond Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (92%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (22%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (100%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 8781% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Double Bond Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Double Bond | XXX | XXX | XXX | XXX | XXX | XXX |
| Cannabis Poland | XXX | XXX | XXX | XXX | XXX | XXX |
| HCW Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| JFL Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Geovax Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| CASI Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Double Bond M&A Activity
Double Bond acquired XXX companies to date.
Last acquisition by Double Bond was on XXXXXXXX, XXXXX. Double Bond acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Double Bond
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDouble Bond Investment Activity
Double Bond invested in XXX companies to date.
Double Bond made its latest investment on XXXXXXXX, XXXXX. Double Bond invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Double Bond
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Double Bond
| When was Double Bond founded? | Double Bond was founded in 1919. |
| Where is Double Bond headquartered? | Double Bond is headquartered in Sweden. |
| How many employees does Double Bond have? | As of today, Double Bond has over 9 employees. |
| Is Double Bond publicly listed? | Yes, Double Bond is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Double Bond? | Double Bond trades under DBP B ticker. |
| When did Double Bond go public? | Double Bond went public in 2015. |
| Who are competitors of Double Bond? | Double Bond main competitors are Cannabis Poland, HCW Biologics, JFL Life Sciences, Geovax Labs. |
| What is the current market cap of Double Bond? | Double Bond's current market cap is $3M. |
| What is the current revenue of Double Bond? | Double Bond's last fiscal year revenue is $9K. |
| What is the current EV/Revenue multiple of Double Bond? | Current revenue multiple of Double Bond is 337.8x. |
| Is Double Bond profitable? | No, Double Bond is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.